Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong financial performance with a 5% YoY revenue increase, improved gross margins, and a 10% rise in net income. EPS growth and robust operating cash flow further support positive sentiment. Although no new strategic initiatives or risk factors were discussed, maintaining guidance and achieving synergy expectations suggest stability. The lack of additional insights from the Q&A limits the sentiment boost, but overall, the financial results and maintained guidance imply a positive market reaction, likely resulting in a 2% to 8% stock price increase.
Revenue Revenue for Q1 2026 was $800 million, representing a 5% increase year-over-year. This growth was driven by strong demand in the activewear segment and improved pricing strategies.
Gross Margin Gross margin improved to 30%, up from 28% in Q1 2025, reflecting better operational efficiencies and cost management.
Net Income Net income for the quarter was $120 million, a 10% increase compared to the same period last year, attributed to higher sales and improved margins.
Earnings Per Share (EPS) EPS rose to $0.60, up from $0.55 in Q1 2025, driven by the increase in net income.
Operating Cash Flow Operating cash flow was $150 million, a 7% increase year-over-year, supported by better working capital management.
The selected topic was not discussed during the call.
The selected topic was not discussed during the call.
Guidance for 2026: Maintaining guidance for 2026 as well as 3-year objectives for the 2026-'28 period.
The selected topic was not discussed during the call.
The earnings call indicates strong financial performance with a 5% YoY revenue increase, improved gross margins, and a 10% rise in net income. EPS growth and robust operating cash flow further support positive sentiment. Although no new strategic initiatives or risk factors were discussed, maintaining guidance and achieving synergy expectations suggest stability. The lack of additional insights from the Q&A limits the sentiment boost, but overall, the financial results and maintained guidance imply a positive market reaction, likely resulting in a 2% to 8% stock price increase.
The earnings call summary indicates mixed results. Basic financial performance shows positive cash flow and asset sales progress, but EBITDA decline in the tissue segment is concerning. Product development is promising with innovation plans, but market strategy is unclear due to potential tariff impacts. The shareholder return plan lacks detail on capital allocation priorities. Q&A insights reveal confidence in price hikes and asset sales without EBITDA erosion, but management's unclear responses on tariffs and asset mix raise uncertainties. Overall, the sentiment is neutral, balancing positive and negative factors.
The earnings call summary highlights strong financial metrics such as an increase in EPS guidance and operating margins, a major acquisition with significant synergies, and an expansive innovation pipeline. The Q&A section supports this positive outlook, with management addressing growth strategies and synergies effectively. However, the unchanged EPS CAGR guide and higher leverage are slight concerns. Overall, the strategic initiatives and optimistic guidance suggest a positive stock price movement, likely in the 2% to 8% range.
The earnings call summary and Q&A reveal a stable market with expected growth in key areas, such as Activewear and Comfort Colors. Despite some concerns in the innerwear business and imprintables market, management expects improvement. Strong financial metrics, including margin improvements and shareholder returns, coupled with optimistic guidance, suggest a positive outlook. The company's strategic positioning amidst tariff challenges also adds to the positive sentiment. Thus, a stock price increase of 2% to 8% is anticipated over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.